BETSEY M STEIMEL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner O FALLON, MO NPI 1376196162
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner MO Boehringer Ingelheim Pharmaceuticals, Inc. All categories
General Payments — all program years on this page
$174.53
- Category: General Payments
- Program years: PY2021–2023
- Record count: 10
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $119.31 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $119.31 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $36.05 | 2 |
| Acerta Pharma LLC | $32.74 | 2 |
| GlaxoSmithKline, LLC. | $20.08 | 1 |
| Amgen Inc. | $17.10 | 1 |
| E.R. Squibb & Sons, L.L.C. | $13.34 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1004317527 | GlaxoSmithKline, LLC. | $20.08 | 05/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1011536717 | AstraZeneca Pharmaceuticals LP | $16.69 | 05/09/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1014832587 | E.R. Squibb & Sons, L.L.C. | $13.34 | 04/13/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015910593 | AstraZeneca Pharmaceuticals LP | $16.05 | 01/24/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1020715013 | Amgen Inc. | $17.10 | 06/05/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996637983 | Boehringer Ingelheim Pharmaceuticals, Inc. | $17.37 | 04/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 996637987 | Boehringer Ingelheim Pharmaceuticals, Inc. | $18.68 | 02/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.